OSI PHARMACEUTICALS INC 4
4 · OSI PHARMACEUTICALS INC · Filed Feb 6, 2007
Insider Transaction Report
Form 4
LOVENBERG WALTER M PHD
Director
Transactions
- Exercise/Conversion
Common Stock
2007-02-05$6.50/sh+6,666$43,329→ 26,848 total - Sale
Common Stock
2007-02-05$35.00/sh−6,666$233,310→ 20,182 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-02-05−6,666→ 6,668 totalExercise: $6.50From: 1998-03-19Exp: 2007-03-18→ Common Stock (6,666 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 plan effective as of January 16, 2007. Transaction occured upon exercise of an option due to expire on March 18, 2007.
- [F2]One third of the stock option becomes exercisable one year after the date of the grant and the remainder vests ratably on a monthly basis over the succeeding 24 months.